These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20153821)

  • 1. Roles for the type III TGF-beta receptor in human cancer.
    Gatza CE; Oh SY; Blobe GC
    Cell Signal; 2010 Aug; 22(8):1163-74. PubMed ID: 20153821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
    Lee JD; Hempel N; Lee NY; Blobe GC
    Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
    Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
    Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type III TGF-beta receptor suppresses breast cancer progression.
    Dong M; How T; Kirkbride KC; Gordon KJ; Lee JD; Hempel N; Kelly P; Moeller BJ; Marks JR; Blobe GC
    J Clin Invest; 2007 Jan; 117(1):206-17. PubMed ID: 17160136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
    Finger EC; Turley RS; Dong M; How T; Fields TA; Blobe GC
    Carcinogenesis; 2008 Mar; 29(3):528-35. PubMed ID: 18174241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells.
    Mythreye K; Knelson EH; Gatza CE; Gatza ML; Blobe GC
    Oncogene; 2013 Mar; 32(11):1416-27. PubMed ID: 22562249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
    Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
    Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
    Ahn JY; Park S; Yun YS; Song JY
    Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
    Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
    Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
    You HJ; How T; Blobe GC
    Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.
    Lee NY; Kirkbride KC; Sheu RD; Blobe GC
    Mol Biol Cell; 2009 Oct; 20(20):4362-70. PubMed ID: 19726563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
    Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
    Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
    Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
    J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.
    Lambert KE; Huang H; Mythreye K; Blobe GC
    Mol Biol Cell; 2011 May; 22(9):1463-72. PubMed ID: 21411633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.
    Mythreye K; Blobe GC
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8221-6. PubMed ID: 19416857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
    del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
    J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
    Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
    McLean S; Di Guglielmo GM
    Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.